Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2026-03-03 @ 3:06 PM
Study NCT ID:
NCT03208335
Status:
UNKNOWN
Last Update Posted:
2017-07-05
First Post:
2017-07-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)
Sponsor:
Chinese PLA General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ChinaPLAGH-HCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None